- Home
- TLSA vs LANV Comparison
TLSA vs LANV Comparison
Compare TLSA & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLSA | LANV |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United Kingdom | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.7M | 201.1M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSA | LANV |
|---|---|---|
| Price | $1.48 | $1.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 414.9K | 43.0K |
| Earning Date | 01-01-0001 | 08-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $341,783,911.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $1.38 |
| 52 Week High | $2.60 | $2.69 |
Technical Indicators
Market Signals| Indicator | TLSA | LANV |
|---|---|---|
| Relative Strength Index (RSI) | 39.51 | 47.86 |
| Support Level | $1.45 | $1.69 |
| Resistance Level | $1.62 | $1.80 |
| Average True Range (ATR) | 0.16 | 0.19 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 35.58 | 54.55 |
Price Performance
Historical ComparisonAbout TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.